Corporate calendar for Evaxion Biotech A/S (EVAX): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to creating artificial intelligence-driven immunotherapies. Its innovative pipeline targets cancers, bacterial infections, and viral diseases.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | ||
| 2026-09-14 | $0.10 | $672M |
| 2026-09-14 | $-0.00 | $3M |
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 |
Stock Splits
| Date | Ratio |
|---|---|
| 2025-01-14 | 1:5 |
| 2024-01-22 | 1:10 |
Price
| Price | $3.03 |
| Market Cap | $19M |
| Exchange | NASDAQ |
| Country | DK |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 4 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 4 |
| Avg rating (1-5) | 1.00 |
Related companies: ANVS · BCAB · BTAI · CELU · GBIO · MURA · PYPD
Explore sector: Healthcare · Biotechnology
More sections of EVAX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks